The U.S. military has decided that it will provide Chelsea Manning with hormone therapy while she is a prisoner at the Army's Fort Leavenworth prison.
If you remember, Manning, the army private who was convicted in the biggest leak of classified information in American history, announced that she was a woman in the summer of 2013. She said she wanted to begin hormone therapy immediately and sued the military to allow it.
According to USA Today, which broke the story, this is the first time the U.S. military makes such an accommodation.
As we've reported, courts in the civil system have decided that not providing hormone therapy to transgender inmates is cruel and unusual punishment, but the same wasn't so of the military.
Earlier this month that changed, USA Today reports:
"After carefully considering the recommendation that (hormone treatment) is medically appropriate and necessary, and weighing all associated safety and security risks presented, I approve adding (hormone treatment) to Inmate Manning's treatment plan," Col. Erica Nelson, the commandant of Fort Leavenworth in Kansas, wrote in a Feb. 5 memo. ...
"Manning has asked for hormone therapy and to be able to live as a woman. Transgenders are not allowed to serve in the U.S. military and the Defense Department does not provide such treatment. The Department of Veterans Affairs, however, does provide the treatment for veterans.
"Last month, Air Force Secretary Deborah Lee James told USA TODAY that the ban on transgender troops is likely to be reassessed and should be lifted."
The AP reports that lawsuit filed by Manning alleged that while the Army was providing some treatment for her gender dysphoria, it was not doing enough.
"[The lawsuit] alleged Manning was at a high risk of self-castration and suicide unless she received more focused treatment," the AP adds.
Manning, formerly known as Bradley, is serving a 35-year-sentence at the maximum security facility.
We reached out to Manning's attorney as well as Fort Leavenworth for comment, but have not heard back. If we do, we'll update this post.